Related Experiment Videos
Nebulized surfactant for experimentally induced otitis media with effusion
A J Nemechek1, N Pahlavan, D N Cote
1Department of Otolaryngology-Head and Neck Surgery, Tulane University School of Medicine, New Orleans, Louisiana 70112-2699, USA.
Summary
Inhaled nebulized surfactants may help treat eustachian tube dysfunction and otitis media with effusion (OME). This pilot study in gerbils showed a potential noninvasive treatment for improved eustachian tube function.
Area of Science:
- Otolaryngology
- Pulmonology
- Biomedical Engineering
Background:
- Eustachian tube dysfunction (ETD) is a common cause of otitis media with effusion (OME).
- Surfactants are hypothesized to be crucial for normal eustachian tube function.
- Previous research indicated improved ETD with topical surfactant application in rodents.
Purpose of the Study:
- To investigate a novel, noninvasive method for delivering surfactants to the eustachian tube.
- To assess the efficacy of inhaled nebulized surfactant in a gerbil model of OME.
Main Methods:
- Otitis media with effusion (OME) was induced in 20 gerbils via transtympanic inoculation of heat-killed Streptococcus pneumoniae.
- Animals with confirmed OME received 5 days of inhaled nebulized surfactant treatment.
- Eustachian tube opening pressures were measured in treated and untreated gerbils.
Main Results:
- OME developed in 67.5% of inoculated ears.
- Eustachian tube opening pressures were successfully obtained in 83.3% of ears.
- The mean opening pressure in treated OME ears (41.4 mmHg) was not significantly different from healthy ears (42.8 mmHg).
Conclusions:
- This pilot study suggests inhaled nebulized surfactant may be a potential treatment for ETD associated with OME.
- The noninvasive delivery method shows promise for clinical application.
- Further research is warranted to confirm the efficacy and optimal parameters for surfactant therapy in OME.